SMD Rise PCL

SMD Rise PCL EBITDA per Share

The EBITDA per Share of SMD Rise PCL (SMD100.BK) as of Oct 20, 2026 is 0.12 THB. In the previous year, EBITDA per Share was 0.45 THB — a change of -73.54% (lower).

EBITDA per Share

0.12THB

YoY

-73.54%

Last updated:

EBITDA per Share of SMD Rise PCL is 2025 0.12 THB. EBITDA per Share of SMD Rise PCL was 2024 0.45 THB. It decreases by -73.54% lower compared to the previous year.

The SMD Rise PCL EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
0.40 THB
Jan 1, 2019
0.65 THB
Jan 1, 2020
0.58 THB
Jan 1, 2021
2.06 THB
Jan 1, 2022
1.80 THB
Jan 1, 2023
0.53 THB
Jan 1, 2024
0.45 THB
Jan 1, 2025
0.12 THB
The SMD Rise PCL EBITDA per Share history
YEAREBITDA per ShareYoY
0.12THB-73.54%
0.45THB-14.34%
0.53THB-70.67%
1.80THB-12.77%
2.06THB+255.33%
0.58THB-11.18%
0.65THB+65.11%
0.40THB+4.30%
0.38THB-14.43%
0.44THB—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SMD Rise PCL Stock analysis

What does SMD Rise PCL do? SMD Rise PCL distributes medical devices and equipment, specializing in respiratory system products. The company imports and distributes medical equipment, supplies, and provides sleep monitoring services. It focuses on sleep disorders like obstructive sleep apnea (OSA), offering counseling and advice on CPAP devices for treatment. The firm targets patients with high blood pressure, diabetes, obesity, and various sleep issues including snoring, insomnia, and daytime sleepiness. Its subsidiary Saint Medical Trading Co.,Ltd handles additional distribution activities. The company generates revenue through the distribution of medical equipment and sleep monitoring services. It serves patients with sleep disorders and chronic conditions such as hypertension, diabetes, and obesity. The primary customers are individuals requiring respiratory support and sleep disorder management, particularly those using CPAP devices for OSA treatment. The business model emphasizes specialized medical equipment distribution and personalized patient counseling. SMD Rise PCL's product portfolio includes medical equipment for respiratory systems and sleep monitoring services. The firm provides services such as counseling on CPAP usage and advice for managing sleep disorders. It caters to specific patient segments, including those with OSA, high blood pressure, diabetes, and obesity. The subsidiary Saint Medical Trading Co.,Ltd supports the distribution network for medical supplies and equipment. SMD Rise PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SMD Rise PCL stock

EBITDA per Share of SMD Rise PCL is 0.12 THB in 2025.

EBITDA per Share of SMD Rise PCL changed from 0.45 THB to 0.12 THB, representing a -73.54% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share SMD Rise PCL since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — SMD Rise PCL

All Key Metrics — SMD Rise PCL